Cellyan Biotechnology Co., Ltd HKPD
1.47 USD +0.04 (+2.80%)
Nov 9, 2026, 11:25 AM EST
1.43 Day range 1.77
1.34 52-week range 29.00
- YTD
- -91.08%
- 1 year
- -93.93%
Revenue & Expenses
Latest period ending Mar 31, 2026 · select a line to chart its full history
Income statement
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 |
|---|---|---|---|---|
| 13.43M | 20.31M | 16.69M | 12.56M | |
| 1.39M | 2.42M | 3.56M | 2.74M | |
| -1.00M | 130.57K | 1.60M | 947.56K | |
| -1.14M | -27.06K | 1.33M | 998.20K | |
| -1.38 | -0.06 | 3.60 | 2.92 |
Balance sheet
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 |
|---|---|---|---|---|
| 221.84K | 749.12K | 627.26K | 524.61K | |
| 12.84M | 9.42M | 8.67M | 3.41M | |
| 3.26M | 4.43M | 4.41M | 2.82M | |
| 1.26M | 2.37M | 2.09M | 680.53K | |
| 9.58M | 4.99M | 4.25M | 585.24K |
Cash flow
| Fiscal year | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 |
|---|---|---|---|---|
| -751.60K | 569.21K | -394.33K | 1.73M | |
| 857.46K | -2.45M | -40.80K | -132.09K | |
| -630.23K | 2.00M | 537.32K | -1.16M | |
| -35.47K | -69.92K | -19.51K | -114.64K | |
| -527.28K | 121.86K | 102.64K | 439.63K |